MIRA INFORM REPORT

 

 

Report Date :

06.08.2014              

 

IDENTIFICATION DETAILS

 

Name :

RETECMA S.A.DE C.V.

 

 

Registered Office :

Oxtopulco 19, Col. Oxtopulco Universidad 04318

 

 

Country :

Mexico

 

 

Date of Incorporation :

Not Available

 

 

Legal Form :

Stock Company of Variable Capital

 

 

Line of Business :

Engaged in the sale of chemical products for the pharmaceutical industry.

 

 

No. of Employees :

30

 

RATING & COMMENTS

 

MIRA’s Rating :

B

 

RATING

STATUS

PROPOSED CREDIT LINE

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

Small

 

Status :

Moderate  

 

 

Payment Behaviour :

Unknown 

 

 

Litigation :

Clear

 

NOTES :

Any query related to this report can be made on e-mail : infodept@mirainform.com while quoting report number, name and date.

 

ECGC Country Risk Classification List – June 01, 2014

 

Country Name

Previous Rating

(31.03.2014)

Current Rating

(01.06.2014)

Mexico

A2

A2

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low Risk

 

A2

Moderate Low Risk

 

B1

Moderate Risk

 

B2

Moderate High Risk

 

C1

High Risk

 

C2

Very High Risk

 

D

 

 

MEXICO - ECONOMIC OVERVIEW

 

Mexico's $1.3 trillion economy has become increasingly oriented toward manufacturing in the 20 years since the North American Free Trade Agreement (NAFTA) entered into force. Per capita income is roughly one-third that of the US; income distribution remains highly unequal. Mexico has become the United States' second-largest export market and third-largest source of imports. In 2013, two-way merchandise trade reached nearly $507 billion. Mexico has free trade agreements with over 50 countries including Guatemala, Honduras, El Salvador, the European Free Trade Area, and Japan - putting more than 90% of trade under free trade agreements. In 2012 Mexico formally joined the Trans-Pacific Partnership negotiations and formed the Pacific Alliance with Peru, Colombia and Chile. Mexico's current government, led by President Enrique PENA NIETO, emphasized economic reforms during its first year in office, passing education, energy, financial, fiscal and telecommunications reform legislation. The three-party "Pact for Mexico" reform agenda aims to improve competitiveness and economic growth across the Mexican economy

Source : CIA

 

 

 

IDENTIFICATION

 

CORRECT COMPANY NAME

RETECMA S.A.DE C.V.

TRADE NAME

RETECMA

TAXPAYER REGISTRATION

RFC RET830823LA9

MAIN ADDRESS

Oxtopulco 19, Col. Oxtopulco Universidad

POSTAL CODE

04318

DEPT/PROV/REGION/STATE

México D.F.

COUNTRY

MEXICO

TELEPHONE

(5255) 54801700

CORPORATE E-MAIL

rdiaz@retecma.com.mx

WEB

www.retecma.com.mx

COMMENTS

 

 
FAX: (5255) 54801700 (Ask for fax tone)

 

EXECUTIVE SUMMARY

permanent employees

30

Chief Executive

DROEGUE MEDICKE, HOLGER

Disposition

UNDETERMINED

Financial Situation

Very few information was given. Politely.

Payments policy

Without rating (No payment experience traced)

Credit (**)

UNDETERMINED RISK.(Insufficient or Non existent information).

Company Size

LARGE COMPANY

Number of times that this company was required: 13

 

 

 

 

 

LEGAL STRUCTURE

 

 

LEGAL STATUS

Stock Company of Variable Capital

 

 

PLACE OF REGISTRY

Mexico, Federal District

 

 

NOTARY OFFICE

 

DURATION

99 years

CURRENT EXCHANGE RATE (US$)

Ps$13.20 Pesos per 1USD

 

 

COMMENTS

 

 
No shareholding information or personal details on the company's executives were revealed.

 

 

DIRECTORS - EXECUTIVES – SHAREHOLDERS

 

 

FULL NAMES / COMPANY NAME

TITLE

%PART.

SINCE

DROEGUE MEDICKE, HOLGER

CEO

 

 

MEDINA, LAURA

Purchasing Department

 

 

RAMIREZ, PAULINA

Imports Department

 

 

DIAZ MARTINEZ, RUBEN

Legal Representative

 

 

AVILA, PAULINA

Human Resources Dept.

 

 

MONTES, MARIANA

Purchasing Department

 

 

 

 

 

WHO IS WHO?

 

 

DROEGUE MEDICKE, HOLGER

TITLE

CEO

NATIONALITY

German

D.O.B.

27SEP1941

TAX ID

DOMD-410927-GUA

 

 

 

 

MEDINA, LAURA

TITLE

Purchasing Department

 

 

ASSOCIATED AS PER OUR DATABASE TO

COMPANY

TAX REG

STA.

COUNTRY

TITLE

MALLACENTRO S.A. DE C.V.

MAL860402AFA

 

MEXICO

 

 

 

 

 

 

 

RELATED COMPANIES TO SUBJECT COMPANY OR TO MAJORITY SHAREHOLDER

 

 

COMPANY NAME

COUNTRY

STA. - TAX REG.

RELATION

ACTIVITY

INMOBILIARIA DROY S.A. DE C.V.

MEXICO

 

Related

 

 

 

 

BUSINESS

 

 

Main activity

 
Subject is engaged in the sale of chemical products for the pharmaceutical industry.
Raw materials for the pharmaceutical industry, nutraceuticals, analgesics, antibacterial drugs, antibiotics, antidiabetics, antidepressants, antidiarrheals, antihistamics, anti-inflammatory drugs, antimicotics, antiparasitics, antiulcerants, cardiovascular drugs, corticoids, expectorants, phytotherapeutic drugs, hormone medications, laxatives, coprocessed active principles, relaxants, vitamins and minerals.
 

O P E R A T I O N S

Import

Yes

Country

USA, Belgium, Germany, Spain, Italy, China.

Export

No

SELLING TerritorY

Domestic market

EMPLOYEES

30

LOCATION

AREA

800 m2

OTHER PREMISES

 
The Tax domicile, Administrative office and Warehouse operate at the main address.
 

Comments

 
Brands sold by the company: RETECMA, KUNA, KROES.

 

 

 

FINANCIAL INFORMATION

 

 

Interviewee(s)

Direct and Indirect Sources

Disposition

Poor. Very few information was given. Politely.

Information provided

 
We spoke with Laura Medina (Purchasing Department) who only provided basic information since she needs to know the supplier's name in order to disclose further information.

 

 

SALES

US$ 0.00 ()

FINANCIAL SITUATION

 
UNDETERMINED
The company's Financial Standing is considered to be UNDETERMINED since there are no financial statements that allow us to asses its results in the last fiscal year.

Comments about insurance and claims?

 

 
No insurance-related information could be obtained.

 

TRADE REFERENCES, CREDIT BUREAU, LAWSUITS, BANKS

(Confidential Information)

Supplier: PROQUIFA, S.A. DE C.V.

Tel.: (55) 13151498

Country: MEXICO

Highest credit? : Not specified

 

 

 

Terms? : Cash

 

Comments : No of purchases are available.

 

Note : Other suppliers did not provide information or could not be consulted

 

Supplier

Country

Comment

MOLÉCULAS FINAS DE MÉXICO, S.A. DE C.V.

MEXICO

They have not replied yet to our request for references.

ZHEJIANG HISOAR PHARMACEUTICAL CO.

CHINA

 

RECORDATI, S.P.A.

ITALY

 

ARTI DRUGS LTD

MALTA

 

MOEHS CATALANA, S.L.

SPAIN

 

 

THE FOLLOWING INFORMATION IS REPORTED BY RISK INFORMATION CENTER

 

No reported banking debt.

 

BANK DEBT REPORTED BY SUPERINTENDENCY OF BANK & INSURANCE (SBS)

 

No reported banking debt.

 


GENERAL COMMENT

The names of the banks where Subject holds accounts could not be obtained.

 

 

LAWSUITS

No Legal Incidents have been found under the company name in Official Bulletins.

CREDIT HISTORY

No trade references were provided by the cited suppliers. Therefore, the Subject's payment history cannot be accurately determined.

 

GENERAL INFORMATION

REPUTATION

 

NOTHING AGAINST COMPANY

 

 

 

FOREIGN EXCHANGE RATES

 

Currency
Unit

Indian Rupees

US Dollar

1

Rs.60.86

UK Pound

1

Rs.102.67

Euro

1

Rs.81.69

 

INFORMATION DETAILS

 

Analysis Done by :

SUB

 

 

Report Prepared by :

PDT

 

               

RATING EXPLANATIONS

 

RATING

STATUS

PROPOSED CREDIT LINE

 

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

 

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

 

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

 

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

 

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

 

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

 

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

Credit not recommended

 

--

NB

New Business

--

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                 Payment record (10%)

Credit history (10%)                    Market trend (10%)                                Operational size (10%)

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.